한국 뇌졸중 진료지침 급성기 치료 중 혈전용해술에 대한 내용의 부분개정

키워드

참고문헌 (40)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995)
2. Schumacher HC, "Use of thrombolysis in acute ischemic stroke: analysis of the nationwide inpatient sample 1999 to 2004", Ann Emerg Med, 50, pp.99~107 (2007)
3. Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean stroke registry study (secular trends in Korean stroke)", Circ Cardiovasc Qual Outcomes, 5, pp.327~334 (2012)
4. Hacke W, "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)", Lancet, 352, pp.1245~1251 (1998)
5. Albers GW, "ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke", Stroke, 33, pp.493~495 (2002)
6. Hacke W, "Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials", Lancet, 363, pp.768~7747 (2004)
7. Hacke W, "Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke", N Engl J Med, 359, pp.1317~1329 (2008)
8. ): a randomised controlled trial, "Lancet", 2012, 2352~2363
9. Wahlgren N, "Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study", Lancet, 372, pp.1303~1309 (2008)
10. Wardlaw JM, "Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and metaanalysis", Lancet, 379, pp.2364~2372 (2012)
11. Tong D, "Are all IV thrombolysis exclusion criteria necessary? Being smart about evidence-based medicine", Neurology, 76, pp.1780~1781 (2011)
12. Balucani C, "Mild stroke and rapidly improving symptoms: it’s not always a happy ending", Stroke, 42, pp.3005~3007 (2011)
13. Smith EE, "Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke", Stroke, 42, pp.3110~3115 (2011)
14. Albers GW, "Stroke treatment academic industry roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies", Stroke, 42, pp.2645~2650 (2011)
15. Mishra NK, "Mismatch-based delayed thrombolysis: a meta-analysis", Stroke, 41, pp.25~33 (2010)
16. Thomalla G, "DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (pre-FLAIR): a multicentre observational study", Lancet Neurol, 10, pp.978~986 (2011)
17. Huisa BN, "Diffusion-weighted imaging-fluid attenuated inversion recovery mismatch in nocturnal stroke patients with unknown time of onset", J Stroke Cerebrovasc Dis (2012)
18. Parsons M, "A randomized trial of tenecteplase versus alteplase for acute ischemic stroke", N Engl J Med, 366, pp.1099~1107 (2012)
19. Sharma VK, "Current status of intravenous thrombolysis for acute ischemic stroke in Asia", Int J Stroke, 6, pp.523~530 (2011)
20. Rha JH, "Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational safe implementation of thrombolysis in stroke-non-European union world (SITS-NEW)", Int J Stroke (2012)
21. Del Zoppo GJ, "Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association", American Stroke Association, 2009, pp.40, 2945~2948
22. "Guidelines for management of ischaemic stroke and transient ischaemic attack"[URL]
23. Lansberg MG, "Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines", Chest, 141, pp.601~636 (2012)
24. Lee M, "Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials", Stroke, 41, pp.932~937 (2010)
25. del Zoppo GJ, "PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Prolyse in acute cerebral thromboembolism", Stroke, 29, pp.4~11 (1998)
26. Schonewille WJ, "Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study", Lancet Neurol, 8, pp.724~730 (2009)
27. Smith WS, "Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial", Stroke, 39, pp.1205~1212 (2008)
28. Nogueira RG, "Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials", Stroke, 40, pp.3777~3783 (2009)
29. The penumbra pivotal stroke trial investigators, "Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease", Stroke, 40, pp.2761~2768 (2009)
30. Tarr R, "The POST trial: initial post-market experience of the penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe", J Neurointerv Surg, 2, pp.341~344 (2010)
31. Hussain SI, "The penumbra system for mechanical thrombectomy in endovascular acute ischemic stroke therapy", Neurology, 79, pp.135~141 (2012)
32. Roth C, "Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions", Stroke, 41, pp.2559~2567 (2010)
33. Saver JL, "Solitaire flow restoration device versus the MERCI retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial", Lancet, 380, pp.1241~1249 (2012)
34. Nogueira RG, "Trevo versus MERCI retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (trevo 2): a randomised trial", Lancet, 380, pp.1231~1240 (2012)
35. Baker WL, "Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence", Ann Intern Med, 154, pp.243~252 (2011)
36. Brinjikji W, "Patient outcomes with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample: 2006 to 2008", Stroke, 42, pp.1648~1652 (2011)
37. Gorelick PB, "Assessment of stent retrievers in acute ischaemic stroke", Lancet, 380, pp.1208~1210 (2012)
38. "NINDS statement. Interventional management of stroke III trial"[URL]
39. Meyers PM, "Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research", Circulation, 119, pp.2235~2249 (2009)
40. Blackham KA, "Endovascular therapy of acute ischemic stroke: report of the standards of practice committee of the society of neurointerventional surgery", J Neurointerv Surg, 4, pp.87~93 (2012)

관련 논문AI추천